Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. (CRDL) Stock Overview

Explore Cardiol Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRDL●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.27
$0.04(3.24%)
U.S. Market is Open · 15:39

Cardiol Therapeutics Inc. (CRDL)

Meyka AI Score

Z

Key Financials

Market Cap142.9M
P/E Ratio-4.52
EPS (TTM)$-0.28
ROE-2.29%
Fundamental Analysis

AI Price Forecasts

1 Month$1.04
3 Months$1.06
1 Year Target$0.52

CRDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cardiol Therapeutics Inc. (CRDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.52 and a market capitalization of 142.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.40%
5-Day Change
12.73%
1-Month Change
16.98%
3-Month Change
-23.93%
6-Month Change
21.57%
Year-to-Date (YTD) Change
30.006%
1-Year Change
1.64%
3-Year Change
41.37%
5-Year Change
-44.39%
All-Time (Max) Change
-66.86%

Contact Information

https://www.cardiolrx.com
289 910 0850
2265 Upper Middle Road East, Oakville, ON, L6H 0G5

Company Facts

180 Employees
IPO DateJan 15, 2019
CountryCA
Actively Trading

Frequently Asked Questions